IJMABHR International Journal of Medical and All Body Health ResearchIJMABHR 2582-8940 Anfo Publication House 127 Proniosomal Gel: A novel drug delivery FotedarShivani NamdevAnshul ChouhanSakshi Singh SharmaMadhuri GuptaPriyanka GuptaArun K Chameli Devi Institute of Pharmacy, Indore, Madhya Pradesh, India 2022 3 2 39 41 05052022 22052022 CC BY-NC-SA 4.0

Different types of drug delivery systems are intended to deliver therapeutic agents to the appropriate site of interest to get desired pharmacological effect. In the field of drug delivery, the advancement of nanotechnology helps to develop novel dosage forms like proniosomes. They are dry formulation of water-soluble carrier particles that are coated with surfactant. They are rehydrated to form niosomal dispersion immediately before use on agitation in hot aqueous media within minutes. Proniosomes are physically stable during the storage and transport. Drug encapsulated in the vesicular structure of proniosomes prolong the existence of drug in the systematic circulation and enhances the penetration into target tissue and reduce toxicity. This article reviews provesicular drug delivery systems with a focus on composition, preparation, the mechanism of drug delivery, encapsulation of the drug into provesicles and characterization techniques.

 Provesiclesproniosomesnovel drug deliverynon-ionic surfactanttransdermal drug deliverytoxicity References Kakr R, Rao R, Goswami A, Nanda S, Saroha K. Proniosomes: An emerging vesicular system in drug delivery and cosmetics. Der Pharmacia Lettre. 2010; 2:227-39 Sankar V, Ruckmani K, Durga S, Jailani S. Proniosomes as drug carriers. Pak J Pharm Sci. 2010; 23:103-7. Goud BA, Raju J, Rambhau D. Improved oral absorption of carbamazepine from sorbiton monolaurate based proniosome systems containing charged surface ligands. Int J Biol Pharm Res. 2012; 3:37-42. Biju SS, Talegaonkar S, Misra PR. Vesicular systems: Anoverview. Indian J Pharm Sci. 2006; 68:141-57. Akhilesh D, Hazel G, Kamath JV. Proniosomes: A propitious provesicular drug carrier. Int J Pharm Pharm Sci Res. 2011; 1(3):98-103. Kakar R, Rao R, Goswami A, Nanda S, Saroha K. Proniosomes: An emerging vesicular system in drug delivery and cosmetics. Der Pharm Lett. 2010; 2(4):227-39. Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery: An overview. Acta Pharm Sin. B 2011; 1(4):208-19. Jadhav KR, Pawar AY, Bachhav AA. Proniosomes: A novel non-ionic pro-vesicles as potential drug carrier. Asian J Pharm. 2016; 10 (3):S210. Azeem A, Jain N, Iqbal Z, Ahmad FJ, Aqil M, Talegaonkar S. Feasibility of proniosomes based transdermal delivery of frusemide: formulation optimization and pharmacotechnical evaluation. Pharm Dev Technol. 2008; 13(2):155-63. doi: 10.1080/10837450701831211.PMID: 18379906. Keservani RK, Sharma AK, Ayaz MD. Novel drug delivery system for the vesicular delivery of drug by the niosomes. Int J Res Control Release. 2011; 1:1-8. Chandra A, Sharma PK. Proniosome based drug delivery system of piroxicam. Afr J Pharm Pharmacol. 2008; 2:184-90. Azarbayjani AF, Tan EH, Chan YW. In vitro drug release of niosomes prepared from various proniosomal haloperidol by proniosomal formulations with non-ionic surfactants. Biol Pharm Bull. 2009; 32:1453-8. El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studies. Eur J Pharm Biopharm. 2011; 77(1):43-55. Malhotra M, Jain NK. Niosomes as drug carriers. Indian Drugs. 1994; 31(3):81-86. Hao Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm. 2002; 244(1-2):73-80. Doi: 10.1016/s0378-5173(02)00301-0. PMID: 12204566.